{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:16:35Z","timestamp":1792844195932,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many low- and middle-income countries, including Latin America, lack access to biomarkers for the diagnosis of prodromal Alzheimer's Disease (AD; mild cognitive impairment due to AD) and AD dementia. MRI visual rating scales may serve as an ancillary diagnostic tool for identifying prodromal AD or AD in Latin America. We investigated the ability of brain MRI visual rating scales to distinguish between cognitively healthy controls, prodromal AD and AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted from a multidisciplinary neurology clinic in Lima, Peru using neuropsychological assessments, brain MRI and cerebrospinal fluid amyloid and tau levels. Medial temporal lobe atrophy (MTA), posterior atrophy (PA), white matter hyperintensity (WMH), and MTA+PA composite MRI scores were compared. Sensitivity, specificity, and area under the curve (AUC) were determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-three patients with prodromal AD, 69 with AD, and 63 cognitively healthy elderly individuals were enrolled. The median age was 75 (8) and 42.7% were men. Neither sex, mean age, nor years of education were significantly different between groups. The MTA was higher in patients with AD (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001) compared with prodromal AD and controls, and MTA scores adjusted by age range (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001) and PA scores (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001) were each significantly associated with AD diagnosis (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001) but not the WMH score (p=0.426). The MTA had better performance among ages &amp;lt;75 years (AUC 0.90 [0.85\u20130.95]), while adjusted MTA+PA scores performed better among ages&amp;gt;75 years (AUC 0.85 [0.79\u20130.92]). For AD diagnosis, MTA+PA had the best performance (AUC 1.00) for all age groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combining MTA and PA scores demonstrates greater discriminative ability to differentiate controls from prodromal AD and AD, highlighting the diagnostic value of visual rating scales in daily clinical practice, particularly in Latin America where access to advanced neuroimaging and CSF biomarkers is limited in the clinical setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2022.962192","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:49:15Z","timestamp":1661993355000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country"],"prefix":"10.3389","volume":"13","author":[{"given":"Nilton","family":"Custodio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Malaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Chambergo-Michilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Moron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Vences","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Huilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio E.","family":"Failoc-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1017\/S1041610209009430","article-title":"Prevalence of dementia in Latin America: a collaborative study of population-based cohorts","volume":"21","author":"Nitrini","year":"2009","journal-title":"Int Psychogeriatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1212\/WNL.0000000000004897","article-title":"Dementia in Latin America Assessing the present and envisioning the future","volume":"90","author":"Parra","year":"2018","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fnagi.2017.00221","article-title":"Dementia in Latin America: Epidemiological evidence and implications for public policy","volume":"9","author":"Custodio","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jalz.2018.12.010","article-title":"Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)","volume":"15","author":"Ramirez Aguilar","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B5","article-title":"Dementia in Latin America: Paving the way toward a regional action plan","volume-title":"Alzheimers Dement","author":"Parra","year":"2020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"Research framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack C","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.633777","article-title":"Expanding representation of low and middle income countries in global dementia research: commentary from the Alzheimer's association","volume":"12","author":"Sexton","year":"2021","journal-title":"Front Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep46263","article-title":"Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications","volume":"7","author":"Ferreira","year":"2017","journal-title":"Scientific Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF00868807","article-title":"Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability","volume":"242","author":"Scheltens","year":"1995","journal-title":"J Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2018.00384","article-title":"Cognitive profiles and atrophy ratings on MRI in senior patients with mild cognitive impairment","volume":"10","author":"Flak","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","article-title":"Visual assessment of posterior atrophy development of a MRI rating scale","volume":"21","author":"Koedam","year":"2011","journal-title":"Eur Radiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s13244-016-0521-6","article-title":"Imaging biomarkers of dementia: recommended visual rating scales with teaching cases","volume":"8","author":"Wahlund","year":"2017","journal-title":"Insights Imaging."},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.640525","article-title":"Neuroimaging research on dementia in brazil in the last decade: scientometric analysis, challenges, and peculiarities","volume-title":"Front Neurol","author":"Rizzi","year":"2021"},{"key":"B14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jalz.2013.09.015","article-title":"Creation of the Argentina-Alzheimer's disease neuroimaging initiative","volume":"10","author":"Russo","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","article-title":"Classifying neurocognitive disorders: the DSM-5 approach","volume":"10","author":"Sachdev","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S1041610204000043","article-title":"& Dickson HG. The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale","volume":"16","author":"Storey","year":"2004","journal-title":"Int Psychogeriatrics."},{"key":"B19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/1533317519869709","article-title":"Validation of the RUDAS in patients with a middle-level education in Lima, Peru","volume":"34","author":"Custodio","year":"2019","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"B20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fneur.2020.00374","article-title":"Validation of the RUDAS for the identification of dementia in illiterate and low-educated older adults in Lima, Peru","volume":"11","author":"Custodio","year":"2020","journal-title":"Front Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/gps.1672","article-title":"Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population","volume":"22","author":"Rami","year":"2007","journal-title":"Int J Geriatr Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnagi.2017.00278","article-title":"Memory alteration test to detect amnestic mild cognitive impairment and early alzheimer's dementia in population with low educational level","volume":"9","author":"Custodio","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1136\/jnnp-2014-310090","article-title":"Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales","volume":"86","author":"Harper","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.neurobiolaging.2006.11.018","article-title":"CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease","volume":"29","author":"Schoonenboom","year":"2008","journal-title":"Neurobiol Aging."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00330-015-4101-9","article-title":"Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition","volume":"26","author":"Ferreira","year":"2016","journal-title":"Eur Radiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2017.00117","article-title":"MRI visual ratings of brain atrophy and white matter hyperintensities across the spectrum of cognitive decline are differently affected by age and diagnosis","volume":"9","author":"Rhodius-Meester","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2214\/ajr.149.2.351","article-title":"signal abnormalities at 1","volume":"8","author":"Fazekas","year":"1987","journal-title":"Am J Neuroradiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00234-019-02188-y","article-title":"Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group","volume":"61","author":"Vernooij","year":"2019","journal-title":"Neuroradiology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-021-02325-2","article-title":"Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population","volume":"21","author":"Molinder","year":"2021","journal-title":"BMC Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-200016","article-title":"Combining visual rating scales for medial temporal lobe atrophy and posterior atrophy to identify amnestic mild cognitive impairment from cognitively normal older adults: evidence based on two cohorts","volume":"77","author":"Sheng","year":"2020","journal-title":"J Alzheimer's Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2010.07.002","article-title":"Volumetic and visual rating of MRI scans in the diagnosis of amnestic MCI and Alzheimer's disease","volume":"7","author":"Loewenstein","year":"2011","journal-title":"Alzheimer Dement"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/brain\/awm112","article-title":"3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease","volume":"130","author":"Whitwell","year":"2007","journal-title":"Brain."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-019-1072-8","article-title":"A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population","volume":"19","author":"Wei","year":"2019","journal-title":"BMC Geriatr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3988\/jcn.2018.14.3.275","article-title":"Age-specific cutoff scores on a t1-weighted axial medial temporal-lobe atrophy visual rating scale in Alzheimer's disease using clinical research center for dementia of South Korea Data","volume":"14","author":"Choi","year":"2018","journal-title":"J Clin Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1007\/s00330-016-4726-3","article-title":"Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population","volume":"27","author":"Claus","year":"2017","journal-title":"Eur Radiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/s-0040-1716806","article-title":"Evaluation of MR visual rating scales in major forms of Dementia","volume":"12","author":"Kaushik","year":"2021","journal-title":"J Neurosci Rural Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1590\/1806-9282.66.4.512","article-title":"Structural volume of hippocampus and Alzheimer's disease","volume":"66","author":"Balestrieri","year":"2020","journal-title":"Rev Assoc Med Bras."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e12026","DOI":"10.1002\/dad2.12026","article-title":"Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging Initiative","volume":"12","author":"Allegri","year":"2020","journal-title":"Alzheimers Dement (Amst)."},{"key":"B39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000477342","article-title":"Visual evaluation of medial temporal lobe atrophy as a clinical marker of conversion from mild cognitive impairment to dementia and for predicting progression in patients with mild cognitive impairment and mild Alzheimer's disease","volume":"44","author":"Persson","year":"2017","journal-title":"Dement Geriatr Cogn Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neurobiolaging.2011.04.003","article-title":"Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease","volume":"33","author":"Lehmann","year":"2012","journal-title":"Neurobiol Aging"},{"key":"B41","doi-asserted-by":"publisher","first-page":"750154","DOI":"10.3389\/fnagi.2021.750154","article-title":"Medial temporal lobe subregional atrophy in aging and Alzheimer's Disease: a longitudinal study","volume":"13","author":"Chauveau","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/jnnp.2005.075341","article-title":"Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease","volume":"77","author":"Van De Pol","year":"2006","journal-title":"J Neurol, Neurosurgery Psychiat."},{"key":"B43","doi-asserted-by":"publisher","first-page":"CD009628","DOI":"10.1002\/14651858.CD009628.pub2","article-title":"Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment","volume":"3","author":"Lombardi","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-150796","article-title":"Low prevalence of mixed dementia in a cohort of 2,000 elderly patients in a memory clinic setting","volume":"50","author":"Claus","year":"2016","journal-title":"J Alzheimer's Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.962192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:49:20Z","timestamp":1661993360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.962192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":44,"alternative-id":["10.3389\/fneur.2022.962192"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.962192","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"962192"}}